{"gene":"OCLN","run_date":"2026-04-29T11:37:57","timeline":{"discoveries":[{"year":1994,"finding":"Occludin's long COOH-terminal cytoplasmic domain (domain E, specifically the ~150 aa subdomain E358/504) is necessary for its localization at tight junctions and directly associates with ZO-1 (and ZO-2 complex) in vitro, suggesting that cytoskeletal anchoring through ZO-1 is required for occludin's tight junction localization.","method":"Deletion mutant transfection in epithelial cells, GST-fusion protein pulldown, in vitro binding assay with recombinant ZO-1","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro binding with mutagenesis, replicated across labs","pmids":["7798316"],"is_preprint":false},{"year":1996,"finding":"Occludin is a conserved integral membrane tight junction protein across mammals (human, mouse, dog, rat-kangaroo); mammalian homologues share ~90% amino acid identity with each other but only ~50% with chicken, establishing the conserved four-transmembrane topology across species.","method":"cDNA cloning and sequence analysis across species","journal":"The Journal of cell biology","confidence":"Medium","confidence_rationale":"Tier 2 — molecular cloning with cross-species validation, single study","pmids":["8601611"],"is_preprint":false},{"year":1998,"finding":"ZO-1 links occludin to the actin cytoskeleton: occludin interacts with a specific domain in the N-terminal (MAGUK-like) half of ZO-1, while the C-terminal proline-rich half of ZO-1 cosediments with F-actin, placing ZO-1 as a molecular bridge between the transmembrane occludin and cortical actin.","method":"Epitope-tagged ZO-1 fragment transfection in MDCK cells, in vitro binding assays, co-sedimentation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro + in vivo localization, replicated by multiple labs","pmids":["9792688"],"is_preprint":false},{"year":1998,"finding":"ZO-3 directly interacts with both ZO-1 and the cytoplasmic domain of occludin (but not ZO-2) in vitro affinity assays, and colocalizes with ZO-1 at tight junctions, identifying ZO-3 as an additional occludin-binding scaffold at the tight junction.","method":"In vitro affinity binding assays with recombinant proteins, immunofluorescence, immunoelectron microscopy","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with structural localization, replicated","pmids":["9531559"],"is_preprint":false},{"year":1999,"finding":"Occludin directly interacts with F-actin in vitro, and ZO-2 also binds directly to occludin; in situ ZO-1, ZO-2, and ZO-3 exist primarily as independent ZO-1·ZO-2 and ZO-1·ZO-3 complexes rather than a trimeric complex, defining the molecular architecture of the tight junction plaque.","method":"Actin cosedimentation assays with purified recombinant proteins, co-immunoprecipitation from MDCK cells, immunofluorescence in cytochalasin D-treated cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro binding + in vivo co-IP, multiple orthogonal methods","pmids":["10575001"],"is_preprint":false},{"year":2002,"finding":"Oxidative stress induces tyrosine phosphorylation of occludin, causing dissociation of occludin–ZO-1 complexes from the cytoskeletal fraction and redistribution from intercellular junctions; tyrosine kinase inhibitor genistein prevents these effects and preserves transepithelial resistance, establishing that tyrosine phosphorylation of occludin regulates its association with ZO-1 and tight junction integrity.","method":"Caco-2 monolayer oxidative stress model, co-immunoprecipitation, Triton-insoluble fractionation, transepithelial resistance measurement, pharmacological inhibition","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP + fractionation + functional resistance readout + pharmacological rescue","pmids":["12169098"],"is_preprint":false},{"year":2003,"finding":"Snail transcription repressor directly binds to E-boxes in the promoters of occludin (and claudin) genes, repressing their transcription during epithelial-mesenchyme transition (EMT), thereby directly coupling EMT to loss of tight junction proteins at the transcriptional level.","method":"Snail overexpression in mouse epithelial cells, promoter reporter assays, electrophoretic mobility shift assay (EMSA), qRT-PCR and western blot for mRNA and protein","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 1/2 — direct promoter binding by EMSA + functional transcriptional repression + multiple methods","pmids":["12668723"],"is_preprint":false},{"year":2005,"finding":"Occludin physically interacts with TGF-β type I receptor (identified by LUMIER technology) and regulates its localization, thereby facilitating efficient TGF-β-dependent dissolution of tight junctions during epithelial-to-mesenchymal transition.","method":"LUMIER (luminescence-based mammalian interactome mapping) high-throughput protein-protein interaction assay, functional TGF-β signaling studies","journal":"Science","confidence":"Medium","confidence_rationale":"Tier 2 — systematic interaction screen with functional follow-up, single lab","pmids":["15761153"],"is_preprint":false},{"year":2008,"finding":"By FRAP analysis in live confluent MDCK monolayers, the majority of occludin (71%) diffuses rapidly within the tight junction membrane with a diffusion constant of ~0.011 µm²/s, in contrast to claudin-1 which is largely stable (76% immobile), demonstrating that the tight junction undergoes constant remodeling with occludin as a highly dynamic component.","method":"Fluorescence recovery after photobleaching (FRAP) in live confluent MDCK monolayers, mathematical modeling of diffusion","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1 — quantitative live-cell FRAP with mathematical modeling, direct localization with functional dynamics","pmids":["18474622"],"is_preprint":false},{"year":2009,"finding":"Human occludin is an essential HCV cell entry factor: overexpression of human OCLN in otherwise non-permissive murine cells renders them infectable with HCV pseudoparticles (HCVpp), and siRNA knockdown of OCLN in permissive human cells impairs both HCVpp and HCVcc infection. Together with CD81, SR-BI, and CLDN1, OCLN is required for HCV entry; species-specific determinants of OCLN were mapped to its second extracellular loop.","method":"cDNA library screening, HCVpp and HCVcc infection assays in murine cells expressing human OCLN, siRNA knockdown in permissive human cells, chimeric/domain-swap constructs","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — complementation assay in murine cells + siRNA knockdown + domain mapping, replicated by independent group","pmids":["19182773"],"is_preprint":false},{"year":2009,"finding":"VEGF-A specifically down-regulates both claudin-5 and occludin protein and mRNA in brain microvascular endothelial cells; recombinant occludin expressed from the same promoter as CLN-5 was not protective against VEGF-induced paracellular permeability increase, whereas CLN-5 was, indicating that occludin loss contributes to but is not the primary determinant of VEGF-mediated BBB breakdown.","method":"Brain microvascular endothelial cell cultures, in vivo microinjection in mouse cerebral cortex, recombinant protein overexpression, permeability assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — in vitro and in vivo experiments with functional permeability readout","pmids":["19174516"],"is_preprint":false},{"year":2009,"finding":"VEGF treatment of endothelial cells induces phosphorylation of occludin on Ser-490 and subsequent ubiquitination; phosphorylated/ubiquitinated occludin traffics from cell borders to early and late endosomes, and occludin interacts with ubiquitin-interacting motif (UIM) proteins Epsin-1, Eps15, and Hrs. Mutating Ser-490 to Ala suppresses VEGF-induced ubiquitination, blocks TJ protein trafficking, and prevents permeability increase; an occludin-ubiquitin chimera disrupts TJs and increases permeability without VEGF.","method":"Co-immunoprecipitation, immunocytochemistry, site-directed mutagenesis (S490A), occludin-ubiquitin chimera overexpression, permeability assays in endothelial cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis + chimera + Co-IP + functional permeability readout, multiple orthogonal methods","pmids":["19478092"],"is_preprint":false},{"year":2008,"finding":"Occludin (along with claudin-1) is required for HCV entry into liver cells and is downregulated during HCV infection to prevent superinfection; mutational analysis of claudin-1 showed that its tight junctional distribution is important for viral entry, supporting a model in which HCV enters from the tight junction.","method":"HCV pseudoparticle entry assays, siRNA knockdown, CLDN1 mutational analysis, HCV infection of Huh-7 cells","journal":"Journal of virology","confidence":"High","confidence_rationale":"Tier 2 — functional entry assays with knockdown and mutational analysis, independent replication of HCV entry role","pmids":["19052094"],"is_preprint":false},{"year":2010,"finding":"The OCLN gene produces multiple alternative splice variants in human liver; only the wild-type (WT-OCLN) and OCLN-ex7ext isoforms, which retain the MARVEL domain, are expressed on the cell membrane and are permissive for HCV infection in vitro. All other isoforms lacking the MARVEL domain are expressed cytoplasmically and are non-permissive, demonstrating that the MARVEL domain and membrane localization are required for occludin's HCV co-receptor function.","method":"RT-PCR cloning of splice variants from human liver, recombinant isoform expression, subcellular localization analysis, HCV infectivity assays in vitro","journal":"Journal of virology","confidence":"High","confidence_rationale":"Tier 2 — systematic isoform characterization with functional infectivity assays, multiple isoforms tested","pmids":["20463075"],"is_preprint":false},{"year":2010,"finding":"MarvelD3 is a novel tight junction MARVEL-domain protein related to occludin and tricellulin; FRAP and protein interaction studies show these three MARVEL proteins have distinct but overlapping functions—marvelD3 can partially compensate for occludin or tricellulin loss but cannot fully restore function, defining the tight junction-associated MARVEL protein (TAMP) family with redundant and unique contributions to epithelial barrier function.","method":"siRNA knockdown, FRAP, immunofluorescence/electron microscopy, protein interaction assays, in vivo immune activation, phylogenetic analysis","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including FRAP, KD with phenotypic readout, protein interaction, in vivo","pmids":["20164257"],"is_preprint":false},{"year":2011,"finding":"Selective siRNA knockdown of occludin in Caco-2 monolayers in vitro and in mouse intestine in vivo causes a preferential increase in macromolecule flux (urea, mannitol, inulin, dextran) without affecting transepithelial resistance, demonstrating that occludin specifically regulates the large-channel tight junction pathway responsible for macromolecule permeability.","method":"siRNA knockdown in Caco-2 monolayers, in vivo mouse intestinal recycling perfusion with siRNA, transepithelial resistance measurement, flux assays with size-graded probes","journal":"American journal of physiology. Gastrointestinal and liver physiology","confidence":"High","confidence_rationale":"Tier 2 — in vitro and in vivo KD with specific functional readout (size-selective permeability)","pmids":["21415414"],"is_preprint":false},{"year":2014,"finding":"miR-122 binds directly to the 3' UTR of OCLN mRNA and down-regulates occludin protein expression; miR-122 overexpression in Huh7.5 cells reduces OCLN protein by ~80%, decreases colocalization of OCLN with CLDN at tight junctions, and reduces HCV pseudoparticle entry by ~42%, establishing miR-122 as a post-transcriptional repressor of OCLN that indirectly inhibits HCV entry.","method":"Dual-luciferase reporter assay with 3'UTR construct, miR-122 mimic/inhibitor transfection, western blot, immunofluorescence co-localization, lentiviral miR-122 overexpression, HCV pseudoparticle and VSV pseudoparticle entry assays","journal":"Liver international","confidence":"High","confidence_rationale":"Tier 2 — direct 3'UTR luciferase validation + protein knockdown + functional entry assay, multiple methods","pmids":["25302477"],"is_preprint":false},{"year":2017,"finding":"miR-144 directly targets OCLN and ZO1 mRNA (validated by dual-luciferase assay with mutant controls); miR-144 overexpression in IBS-D rat colonic epithelial cells decreases OCLN and ZO1 expression and enhances intestinal hyperpermeability, while inhibition of miR-144 or rescue overexpression of OCLN/ZO1 reverses hyperpermeability, establishing miR-144 as a direct post-transcriptional repressor of OCLN.","method":"miRNA microarray, qRT-PCR, western blot, ELISA, dual-luciferase assay with 3'UTR mutants, miRNA mimic/inhibitor transfection, rescue overexpression experiments in colonic epithelial cells","journal":"Cellular physiology and biochemistry","confidence":"High","confidence_rationale":"Tier 2 — 3'UTR luciferase with mutation controls + protein expression + functional permeability + rescue experiment","pmids":["29258088"],"is_preprint":false},{"year":2024,"finding":"S. pneumoniae releases extracellular vesicles (pEVs) containing the virulence kinase StkP; internalized StkP phosphorylates BECN1 at Ser93 and Ser96, initiating autophagy, which leads to autophagosomal degradation of OCLN and consequent alveolar epithelial barrier dysfunction. Deletion of stkP in S. pneumoniae abolishes pEV-induced OCLN degradation and protects mice from death.","method":"Proteomics of pEV cargo, co-immunoprecipitation, phosphorylation site identification, autophagy inhibitors (BafA1, CQ), BECN1 mutants, CRISPR KO of stkP, TEER measurement, in vivo mouse infection model","journal":"Autophagy","confidence":"High","confidence_rationale":"Tier 2 — mechanistic pathway from kinase to substrate to autophagy to OCLN degradation, confirmed in vivo with KO","pmids":["38497494"],"is_preprint":false},{"year":2025,"finding":"The OCLN carboxy-terminus forms a complex with the light intermediate chain (LIC) of dynein, linking tight junction cargo to the minus-end-directed motor protein. Ser471 phosphorylation is required for LIC binding, while Ser490 phosphorylation is required for trafficking. Expression of the S490A mutant prevents endothelial cell proliferation and collateral angiogenesis. OCLN gene deletion targeting exon 5 (preventing both full-length and isoform 4 expression) results in embryonic lethality.","method":"Co-immunoprecipitation, site-directed mutagenesis (S471A, S490A), endothelial cell proliferation assays, collateral angiogenesis model, exon 5-targeted gene deletion (embryonic lethality phenotype)","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP with mutagenesis + functional cellular and in vivo phenotypes, preprint not yet peer-reviewed","pmids":["bio_10.1101_2025.06.12.659326"],"is_preprint":true},{"year":2025,"finding":"Occludin silencing (ocln KD) in brain endothelial cells alters gene expression signatures of innate immunity including IFN-stimulated genes and the RIG-1/MAVS antiviral signaling pathway, and causes dysfunctional mitochondrial bioenergetics and autophagy; in EcoHIV-infected ocln-deficient mice, these alterations translate to worsened ischemic stroke outcomes, identifying occludin as a regulator of innate immune responses and mitochondrial dynamics in the BBB.","method":"Occludin siRNA knockdown in brain endothelial cells, gene expression profiling, mitochondrial bioenergetics assays, EcoHIV infection in ocln-deficient mice, ischemic stroke model","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — KD with gene expression + functional mitochondrial assays + in vivo stroke model, preprint","pmids":["bio_10.1101_2024.06.07.598027"],"is_preprint":true},{"year":2021,"finding":"miR-122-5p in LPS-induced neutrophil exosomes directly targets OCLN mRNA (validated by dual-luciferase assay), downregulates OCLN expression in brain microvascular endothelial cells, and promotes apoptosis, oxidative stress, and increased permeability; OCLN overexpression partially reverses these effects.","method":"Dual-luciferase reporter assay, western blot, exosome co-culture, flow cytometry (apoptosis), ROS assays, OCLN overexpression rescue","journal":"American journal of translational research","confidence":"Medium","confidence_rationale":"Tier 2 — 3'UTR luciferase + functional rescue, single lab","pmids":["34150006"],"is_preprint":false},{"year":2025,"finding":"miR-20a overexpression in a sepsis model inhibits DUSP3 (a target of miR-20a), which in turn suppresses ubiquitination of OCLN, thereby preserving OCLN protein levels and intestinal barrier integrity; OCLN knockdown abolishes the protective effect of miR-20a overexpression, placing OCLN downstream of the miR-20a/DUSP3 axis in barrier regulation.","method":"CLP mouse sepsis model and LPS-treated NCM460 cells, miR-20a mimic/DUSP3 OE/KD/OCLN KD, western blot, RT-qPCR, ELISA, flow cytometry, immunofluorescence, HE staining","journal":"In vitro cellular & developmental biology. Animal","confidence":"Medium","confidence_rationale":"Tier 2 — pathway epistasis with KD/OE + in vivo model, single lab","pmids":["40392484"],"is_preprint":false}],"current_model":"Occludin (OCLN) is a four-transmembrane MARVEL-domain tight junction protein whose long COOH-terminal cytoplasmic tail directly associates with ZO-1 (and ZO-3) to anchor it to the cortical actin cytoskeleton; it acts as a highly dynamic membrane component that regulates the large-channel paracellular pathway for macromolecule flux, undergoes Ser-490 phosphorylation-driven ubiquitination to mediate VEGF-induced endosomal trafficking and vascular permeability, serves as an essential HCV co-entry factor through its second extracellular loop and MARVEL domain, is transcriptionally repressed by Snail during EMT, and—as newly described—links tight junction cargo to the dynein motor via its carboxy-terminus to regulate trafficking and collateral angiogenesis, while also modulating innate immune and mitochondrial signaling at the blood-brain barrier."},"narrative":{"teleology":[{"year":1994,"claim":"The molecular basis of occludin's tight junction localization was established by demonstrating that its COOH-terminal cytoplasmic domain directly binds ZO-1, resolving how a transmembrane protein is tethered at the junctional plaque.","evidence":"Deletion mutant transfection in epithelial cells and GST-pulldown with recombinant ZO-1","pmids":["7798316"],"confidence":"High","gaps":["Binding affinity and stoichiometry of the occludin–ZO-1 interaction were not determined","Whether ZO-1 binding is required for occludin function versus merely localization was unclear"]},{"year":1998,"claim":"ZO-1 was shown to function as a molecular bridge connecting occludin to cortical actin, with additional scaffolding provided by ZO-3, establishing the tripartite architecture of the tight junction plaque.","evidence":"In vitro binding/cosedimentation assays and fragment transfection in MDCK cells for ZO-1; affinity assays and immunoelectron microscopy for ZO-3","pmids":["9792688","9531559"],"confidence":"High","gaps":["Structural basis of the ZO-1 bridging function was not resolved","Relative contributions of ZO-2 versus ZO-3 to occludin anchoring remained unclear"]},{"year":1999,"claim":"Occludin was found to bind F-actin directly in addition to its indirect linkage through ZO proteins, and ZO-1·ZO-2 and ZO-1·ZO-3 were shown to exist as separate dimeric complexes rather than a single trimeric scaffold, refining the junctional plaque model.","evidence":"Actin cosedimentation with recombinant protein and co-IP from MDCK cells","pmids":["10575001"],"confidence":"High","gaps":["Functional consequence of direct occludin–actin binding was not tested","Whether direct actin binding is regulated by phosphorylation was unknown"]},{"year":2002,"claim":"Tyrosine phosphorylation was identified as a regulatory switch for occludin–ZO-1 association and tight junction integrity, linking oxidative stress signaling to barrier disruption.","evidence":"Oxidative stress in Caco-2 monolayers with co-IP, fractionation, TER measurement, and genistein rescue","pmids":["12169098"],"confidence":"High","gaps":["Specific tyrosine residues phosphorylated were not identified","The kinase(s) responsible were not determined"]},{"year":2003,"claim":"Snail was shown to directly repress occludin transcription by binding E-box elements in its promoter, providing the first transcriptional mechanism coupling EMT to tight junction dissolution.","evidence":"Snail overexpression, promoter reporters, and EMSA in mouse epithelial cells","pmids":["12668723"],"confidence":"High","gaps":["Whether other EMT transcription factors also target OCLN was not addressed","Chromatin-level regulation was not examined"]},{"year":2008,"claim":"FRAP experiments revealed that occludin is a highly dynamic component of the tight junction (71% mobile fraction) in contrast to the largely immobile claudin-1, establishing that the tight junction undergoes constitutive remodeling driven by occludin turnover.","evidence":"Quantitative FRAP with mathematical modeling in live confluent MDCK monolayers","pmids":["18474622"],"confidence":"High","gaps":["Molecular determinants controlling occludin's high mobility were not identified","Whether dynamic exchange is required for barrier function was not tested"]},{"year":2009,"claim":"Occludin was identified as an essential HCV co-entry factor, with species-specific determinants mapped to the second extracellular loop, answering why murine cells resist HCV infection and establishing OCLN alongside CD81, SR-BI, and CLDN1 as the minimal receptor complex.","evidence":"cDNA library complementation in murine cells, HCVpp/HCVcc assays, siRNA knockdown, domain-swap chimeras","pmids":["19182773","19052094"],"confidence":"High","gaps":["Whether occludin directly contacts viral particles or acts indirectly was unresolved","The step in the entry cascade requiring occludin was not pinpointed"]},{"year":2009,"claim":"VEGF-induced Ser-490 phosphorylation was shown to trigger occludin ubiquitination and endosomal trafficking via Epsin-1, Eps15, and Hrs, providing a complete signaling-to-trafficking mechanism for vascular permeability regulation.","evidence":"Site-directed mutagenesis (S490A), occludin–ubiquitin chimera, co-IP, permeability assays in endothelial cells","pmids":["19478092"],"confidence":"High","gaps":["The E3 ubiquitin ligase responsible for occludin ubiquitination was not identified","Whether this pathway operates in non-endothelial epithelia was untested"]},{"year":2010,"claim":"Systematic isoform characterization demonstrated that MARVEL domain integrity and membrane localization are required for occludin's HCV co-receptor function, and identification of MarvelD3 defined the TAMP family with partially redundant barrier roles.","evidence":"RT-PCR isoform cloning from human liver with infectivity assays; siRNA/FRAP/EM for TAMP family analysis","pmids":["20463075","20164257"],"confidence":"High","gaps":["Structural basis of MARVEL domain function in HCV entry was unknown","Extent of TAMP redundancy in vivo was not determined"]},{"year":2011,"claim":"Selective knockdown in vitro and in vivo demonstrated that occludin specifically controls the large-channel paracellular pathway for macromolecule flux without affecting ion permeability (TER), resolving its distinct functional role from claudins.","evidence":"siRNA in Caco-2 monolayers and in vivo mouse intestinal perfusion with size-graded probes","pmids":["21415414"],"confidence":"High","gaps":["Structural mechanism by which occludin controls large-channel permeability was not defined","Whether this pathway is regulated dynamically by phosphorylation was not tested"]},{"year":2014,"claim":"Post-transcriptional regulation of OCLN was established by identifying miR-122 and later miR-144 as direct repressors targeting the OCLN 3'UTR, linking microRNA networks to barrier integrity and HCV susceptibility.","evidence":"Dual-luciferase 3'UTR reporter assays, miRNA mimic/inhibitor, protein quantification, functional entry and permeability assays","pmids":["25302477","29258088"],"confidence":"High","gaps":["Relative contribution of miR-122-mediated OCLN repression versus its direct proviral role in HCV replication was not disentangled","Whether these miRNAs regulate OCLN in vivo at the BBB was unknown"]},{"year":2024,"claim":"A pathogen-driven degradation mechanism was uncovered: pneumococcal StkP kinase phosphorylates BECN1 to initiate autophagosomal degradation of occludin, establishing autophagy as a distinct pathway for barrier disruption during bacterial infection.","evidence":"Proteomics, co-IP, phosphorylation site identification, autophagy inhibitors, BECN1 mutants, CRISPR KO of stkP, in vivo mouse infection","pmids":["38497494"],"confidence":"High","gaps":["Whether occludin is a direct autophagy cargo receptor substrate or is degraded indirectly was not resolved","Generalizability to other bacterial infections was untested"]},{"year":2025,"claim":"Occludin's COOH-terminus was found to link tight junction cargo to the dynein motor via its light intermediate chain, with Ser-471 phosphorylation required for motor engagement and Ser-490 phosphorylation required for trafficking; exon 5 deletion causes embryonic lethality, demonstrating that occludin is essential for development.","evidence":"Co-IP, site-directed mutagenesis, endothelial proliferation assays, collateral angiogenesis model, exon 5-targeted gene deletion (preprint)","pmids":["bio_10.1101_2025.06.12.659326"],"confidence":"Medium","gaps":["Preprint not yet peer-reviewed","Structural details of occludin–dynein LIC interface are unknown","Whether dynein-mediated trafficking is relevant to all occludin-dependent barrier functions was not tested"]},{"year":null,"claim":"Key open questions remain: the E3 ubiquitin ligase mediating VEGF-induced occludin ubiquitination has not been identified, the structural basis of the MARVEL domain's roles in barrier function and HCV entry is unresolved, and whether occludin's newly described roles in innate immunity and mitochondrial dynamics at the BBB operate through its canonical junctional function or represent junction-independent signaling remains to be dissected.","evidence":"","pmids":[],"confidence":"Low","gaps":["E3 ligase identity unknown","No high-resolution structure of full-length occludin","Junction-independent signaling mechanisms are poorly defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098631","term_label":"cell adhesion mediator activity","supporting_discovery_ids":[0,2,8,15]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0,2,4,15]},{"term_id":"GO:0001618","term_label":"virus receptor activity","supporting_discovery_ids":[9,12,13]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,1,8,9,13,15]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[11]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[2,4]}],"pathway":[{"term_id":"R-HSA-1500931","term_label":"Cell-Cell communication","supporting_discovery_ids":[0,2,4,8,15]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[5,7,11]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[6,7]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[18]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[9,12,13]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[11]}],"complexes":["Tight junction plaque (ZO-1·occludin·ZO-3 scaffold)"],"partners":["TJP1","TJP2","TJP3","CLDN1","MARVELD3","TGFBR1"],"other_free_text":[]},"mechanistic_narrative":"Occludin is a four-transmembrane MARVEL-domain tight junction protein that regulates paracellular permeability, particularly the large-channel pathway controlling macromolecule flux, through its dynamic residency at tight junctions and phosphorylation-dependent trafficking [PMID:21415414, PMID:18474622]. Its long COOH-terminal cytoplasmic tail directly binds ZO-1, ZO-2, ZO-3, and F-actin, anchoring it to the cortical cytoskeleton, while phosphorylation at Ser-490 drives ubiquitination and endosomal trafficking that increases vascular permeability in response to VEGF [PMID:7798316, PMID:9792688, PMID:19478092]. Occludin serves as an essential hepatitis C virus co-entry factor through its second extracellular loop and MARVEL domain, is transcriptionally repressed by Snail during epithelial-mesenchymal transition, and is post-transcriptionally downregulated by miR-122 and miR-144 [PMID:19182773, PMID:12668723, PMID:25302477, PMID:29258088]. Occludin also undergoes autophagosomal degradation triggered by pneumococcal StkP-mediated BECN1 phosphorylation, contributing to alveolar barrier disruption during infection [PMID:38497494]."},"prefetch_data":{"uniprot":{"accession":"Q16625","full_name":"Occludin","aliases":[],"length_aa":522,"mass_kda":59.1,"function":"May play a role in the formation and regulation of the tight junction (TJ) paracellular permeability barrier. It is able to induce adhesion when expressed in cells lacking tight junctions (Microbial infection) Acts as a coreceptor for hepatitis C virus (HCV) in hepatocytes","subcellular_location":"Cell membrane; Cell junction, tight junction","url":"https://www.uniprot.org/uniprotkb/Q16625/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/OCLN","classification":"Not Classified","n_dependent_lines":31,"n_total_lines":1208,"dependency_fraction":0.02566225165562914},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/OCLN","total_profiled":1310},"omim":[{"mim_id":"621451","title":"SMALL NUCLEOLAR RNA HOST GENE 12; SNHG12","url":"https://www.omim.org/entry/621451"},{"mim_id":"621447","title":"ZINC FINGER PROTEIN 787; ZNF787","url":"https://www.omim.org/entry/621447"},{"mim_id":"617579","title":"CLAUDIN 10; CLDN10","url":"https://www.omim.org/entry/617579"},{"mim_id":"617005","title":"CLAUDIN 17; CLDN17","url":"https://www.omim.org/entry/617005"},{"mim_id":"616432","title":"RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 18; ARHGEF18","url":"https://www.omim.org/entry/616432"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"},{"location":"Cell Junctions","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"thyroid gland","ntpm":29.4}],"url":"https://www.proteinatlas.org/search/OCLN"},"hgnc":{"alias_symbol":["PPP1R115"],"prev_symbol":[]},"alphafold":{"accession":"Q16625","domains":[{"cath_id":"-","chopping":"54-91_133-199_240-281","consensus_level":"high","plddt":82.4771,"start":54,"end":281},{"cath_id":"1.10.287","chopping":"414-520","consensus_level":"high","plddt":91.3524,"start":414,"end":520}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q16625","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q16625-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q16625-F1-predicted_aligned_error_v6.png","plddt_mean":65.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=OCLN","jax_strain_url":"https://www.jax.org/strain/search?query=OCLN"},"sequence":{"accession":"Q16625","fasta_url":"https://rest.uniprot.org/uniprotkb/Q16625.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q16625/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q16625"}},"corpus_meta":[{"pmid":"29258088","id":"PMC_29258088","title":"MiR-144 Increases Intestinal Permeability in IBS-D Rats by Targeting OCLN and ZO1.","date":"2017","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/29258088","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32807750","id":"PMC_32807750","title":"Lactobacillus casei LC01 Regulates Intestinal Epithelial Permeability through miR-144 Targeting of OCLN and ZO1.","date":"2020","source":"Journal of microbiology and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/32807750","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20463075","id":"PMC_20463075","title":"Splicing diversity of the human OCLN gene and its biological significance for hepatitis C virus entry.","date":"2010","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/20463075","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38497494","id":"PMC_38497494","title":"Streptococcus pneumoniae extracellular vesicles aggravate alveolar epithelial barrier disruption via autophagic degradation of OCLN (occludin).","date":"2024","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/38497494","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34150006","id":"PMC_34150006","title":"Exosomes containing miR-122-5p secreted by LPS-induced neutrophils regulate the apoptosis and permeability of brain microvascular endothelial cells by targeting OCLN.","date":"2021","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/34150006","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28179633","id":"PMC_28179633","title":"Band-like calcification with simplified gyration and polymicrogyria: report of 10 new families and identification of five novel OCLN mutations.","date":"2017","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28179633","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25302477","id":"PMC_25302477","title":"MiR-122 decreases HCV entry into hepatocytes through binding to the 3' UTR of OCLN mRNA.","date":"2014","source":"Liver international : official journal of the International Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/25302477","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28490769","id":"PMC_28490769","title":"Increased cerebral expressions of MMPs, CLDN5, OCLN, ZO1 and AQPs are associated with brain edema following fatal heat stroke.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28490769","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28184927","id":"PMC_28184927","title":"Downregulation of OCLN and GAS1 in clear cell renal cell carcinoma.","date":"2017","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/28184927","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28386946","id":"PMC_28386946","title":"Comprehensive molecular screening strategy of OCLN in band-like calcification with simplified gyration and polymicrogyria.","date":"2017","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28386946","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32056224","id":"PMC_32056224","title":"Tree shrew bone marrow-derived mesenchymal stem cells express CD81, OCLN, and miR-122, facilitating the entire hepatitis C virus life cycle.","date":"2020","source":"Journal of medical virology","url":"https://pubmed.ncbi.nlm.nih.gov/32056224","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32240828","id":"PMC_32240828","title":"A homozygote frameshift mutation in OCLN gene result in Pseudo-TORCH syndrome type I: A case report extending the phenotype with central diabetes insipidus and renal dysfunction.","date":"2020","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32240828","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30814850","id":"PMC_30814850","title":"Effect of calprotectin subunit S100A9 on the expression and methylation of OCLN in human melanoma cell line A-375.","date":"2017","source":"Turkish journal of biology = Turk biyoloji dergisi","url":"https://pubmed.ncbi.nlm.nih.gov/30814850","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34704946","id":"PMC_34704946","title":"OCLN gene variants identified in three patients with severe neurodevelopmental disorder associated with epilepsy, intellectual disability and malformation of cortical development.","date":"2021","source":"Epileptic disorders : international epilepsy journal with videotape","url":"https://pubmed.ncbi.nlm.nih.gov/34704946","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28053600","id":"PMC_28053600","title":"Alginate-embedded HuH-7 cells increase MMP-9 and reduce OCLN expression in vitro.","date":"2017","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/28053600","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35834877","id":"PMC_35834877","title":"LncRNA ALDB-898 modulates intestinal epithelial cell damage caused by Clostridium perfringens type C in piglet by regulating ssc-miR-122-5p/OCLN signaling.","date":"2022","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35834877","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34573918","id":"PMC_34573918","title":"A Fetus with Congenital Microcephaly, Microphthalmia and Cataract Was Detected with Biallelic Variants in the OCLN Gene: A Case Report.","date":"2021","source":"Diagnostics (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/34573918","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34515239","id":"PMC_34515239","title":"MiR-224-5p Targeting OCLN Promotes the Proliferation, Migration, and Invasion of Clear Cell Renal Cell Carcinoma Cells.","date":"2021","source":"Urologia internationalis","url":"https://pubmed.ncbi.nlm.nih.gov/34515239","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41594443","id":"PMC_41594443","title":"Testicular Gap (CX43) and Tight Junction (OCLN, CLDN3, 5 and 11) Components in the Dog Are Affected by GnRH-Mediated Downregulation.","date":"2026","source":"Animals : an open access journal from MDPI","url":"https://pubmed.ncbi.nlm.nih.gov/41594443","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40392484","id":"PMC_40392484","title":"Overexpression of miR-20a targeting DUSP3 inhibits OCLN ubiquitination levels and alleviates sepsis induced intestinal barrier dysfunction.","date":"2025","source":"In vitro cellular & developmental biology. Animal","url":"https://pubmed.ncbi.nlm.nih.gov/40392484","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.11.17.688818","title":"Vascular Basement Membrane Laminins Modulate Functional Zonation of Cerebral Microvessels","date":"2025-11-17","source":"bioRxiv","url":"https://doi.org/10.1101/2025.11.17.688818","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.06.12.659326","title":"Occludin Acts as a Dynein Adaptor Regulating Permeability and Collateral Angiogenesis","date":"2025-06-15","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.12.659326","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.09.18.677083","title":"Nutritional vitamin E or plant extracts affect the immune response and mammary epithelium integrity during intramammary lipopolysaccharide challenge in early lactation","date":"2025-09-22","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.18.677083","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.10.21.683634","title":"Human cortico-vascular assembloids reveal a CELF2-AHNAK-dependent switch from neuronal to endothelial tropism in glioblastoma cells","date":"2025-10-22","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.21.683634","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.04.16.649253","title":"Shift in gut microbiota composition and mitigation of diet-induced atherogenesis in mice after prolonged consumption of a traditionally fermented soybean","date":"2025-04-17","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.16.649253","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.02.24.639874","title":"<i>NOR1</i> and Mitophagy: An Insight into Sertoli Cell Function Regulating Spermatogenesis","date":"2025-02-26","source":"bioRxiv","url":"https://doi.org/10.1101/2025.02.24.639874","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.02.05.636626","title":"Sex-dependent effects of intestinal epithelial TLR4 deletion induced before activity-based anorexia","date":"2025-02-08","source":"bioRxiv","url":"https://doi.org/10.1101/2025.02.05.636626","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2024.06.07.598027","title":"MITOCHONDRIAL ANTIVIRAL PATHWAYS CONTROL ANTI-HIV RESPONSES AND ISCHEMIC STROKE OUTCOMES VIA THE RIG-1 SIGNALING AND INNATE IMMUNITY MECHANISMS","date":"2024-06-08","source":"bioRxiv","url":"https://doi.org/10.1101/2024.06.07.598027","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"11181995","id":"PMC_11181995","title":"The sequence of the human genome.","date":"2001","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/11181995","citation_count":8428,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17525332","id":"PMC_17525332","title":"ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.","date":"2007","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/17525332","citation_count":2519,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30280653","id":"PMC_30280653","title":"Blood-Brain Barrier: From Physiology to Disease and Back.","date":"2019","source":"Physiological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/30280653","citation_count":1645,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9792688","id":"PMC_9792688","title":"The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9792688","citation_count":1142,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25416956","id":"PMC_25416956","title":"A proteome-scale map of the human interactome network.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25416956","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10601346","id":"PMC_10601346","title":"Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins.","date":"1999","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10601346","citation_count":921,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7798316","id":"PMC_7798316","title":"Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin at tight junctions.","date":"1994","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/7798316","citation_count":791,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19182773","id":"PMC_19182773","title":"Human occludin is a hepatitis C virus entry factor required for infection of mouse cells.","date":"2009","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/19182773","citation_count":728,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12668723","id":"PMC_12668723","title":"Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail.","date":"2003","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/12668723","citation_count":557,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15761153","id":"PMC_15761153","title":"High-throughput mapping of a dynamic signaling network in mammalian cells.","date":"2005","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/15761153","citation_count":553,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19174516","id":"PMC_19174516","title":"VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19174516","citation_count":548,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9531559","id":"PMC_9531559","title":"ZO-3, a novel member of the MAGUK protein family found at the tight junction, interacts with ZO-1 and occludin.","date":"1998","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/9531559","citation_count":469,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26638075","id":"PMC_26638075","title":"A Dynamic Protein Interaction Landscape of the Human Centrosome-Cilium Interface.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26638075","citation_count":433,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10575001","id":"PMC_10575001","title":"Protein interactions at the tight junction. Actin has multiple binding partners, and ZO-1 forms independent complexes with ZO-2 and ZO-3.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10575001","citation_count":384,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12169098","id":"PMC_12169098","title":"Tyrosine phosphorylation and dissociation of occludin-ZO-1 and E-cadherin-beta-catenin complexes from the cytoskeleton by oxidative stress.","date":"2002","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/12169098","citation_count":345,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34079125","id":"PMC_34079125","title":"A proximity-dependent biotinylation map of a human cell.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34079125","citation_count":339,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21415414","id":"PMC_21415414","title":"Occludin regulates macromolecule flux across the intestinal epithelial tight junction barrier.","date":"2011","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/21415414","citation_count":324,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19478092","id":"PMC_19478092","title":"Occludin phosphorylation and ubiquitination regulate tight junction trafficking and vascular endothelial growth factor-induced permeability.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19478092","citation_count":293,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18474622","id":"PMC_18474622","title":"The tight junction protein complex undergoes rapid and continuous molecular remodeling at steady state.","date":"2008","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/18474622","citation_count":276,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19052094","id":"PMC_19052094","title":"Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection.","date":"2008","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/19052094","citation_count":268,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8601611","id":"PMC_8601611","title":"Interspecies diversity of the occludin sequence: cDNA cloning of human, mouse, dog, and rat-kangaroo homologues.","date":"1996","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/8601611","citation_count":262,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20164257","id":"PMC_20164257","title":"Tight junction-associated MARVEL proteins marveld3, tricellulin, and occludin have distinct but overlapping functions.","date":"2010","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/20164257","citation_count":260,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":18883,"output_tokens":2339,"usd":0.045867},"stage2":{"model":"claude-opus-4-6","input_tokens":5648,"output_tokens":2063,"usd":0.119722},"total_usd":0.461656,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":32018,"output_tokens":5980,"usd":0.092877},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":9792,"output_tokens":3460,"usd":0.20319}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2010,\n      \"finding\": \"OCLN splice variants that retain the MARVEL domain are expressed on the cell membrane and are permissive for HCV infection in vitro, whereas variants lacking the MARVEL domain are expressed in the cytoplasm and are nonpermissive for HCV infection, identifying the MARVEL domain as the functional unit required for HCV entry.\",\n      \"method\": \"In vitro HCV infectivity assay with recombinant OCLN isoforms; cellular localization by expression studies\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — reconstitution/infectivity assay with multiple isoforms and domain mapping, moderate evidence from single lab with orthogonal methods\",\n      \"pmids\": [\"20463075\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"miR-122 binds the 3′ UTR of OCLN mRNA and down-regulates OCLN protein expression, thereby reducing HCV entry into hepatocytes.\",\n      \"method\": \"Dual-luciferase reporter assay with OCLN 3′ UTR construct; lentiviral miR-122 overexpression; HCV pseudoparticle infectivity assay\",\n      \"journal\": \"Liver international\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct 3′ UTR binding validated by luciferase, protein knockdown confirmed, functional HCV entry assay\",\n      \"pmids\": [\"25302477\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"miR-144 directly targets OCLN and ZO1 mRNAs in colonic epithelial cells, reducing their expression and increasing intestinal permeability; rescue by OCLN/ZO1 overexpression reversed miR-144-driven hyperpermeability.\",\n      \"method\": \"Dual-luciferase reporter assay (mutant target site controls); miRNA mimics/inhibitors transfection; Western blot; functional permeability assay in IBS-D rat colonic epithelial cells\",\n      \"journal\": \"Cellular physiology and biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct target validation by luciferase with mutant controls, rescue experiment, multiple orthogonal methods\",\n      \"pmids\": [\"29258088\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Lactobacillus casei LC01 decreases miR-144 expression in intestinal epithelial cells, leading to upregulation of OCLN and ZO1 and enhanced epithelial barrier function; OCLN/ZO1 overexpression eliminates miR-144-driven permeability increase.\",\n      \"method\": \"miRNA microarray; qRT-PCR; Western blot; ELISA; RNA oligoribonucleotide transfection; permeability (FD4) assay\",\n      \"journal\": \"Journal of microbiology and biotechnology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — single lab replicating the miR-144/OCLN mechanism with added Lactobacillus context; moderate methods\",\n      \"pmids\": [\"32807750\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"miR-122-5p secreted in LPS-induced neutrophil exosomes directly targets OCLN mRNA to downregulate OCLN protein in brain microvascular endothelial cells, causing increased permeability and apoptosis; OCLN overexpression partially rescues these effects.\",\n      \"method\": \"Dual-luciferase reporter assay; Western blot; flow cytometry; exosome co-culture with BMECs; OCLN rescue overexpression\",\n      \"journal\": \"American journal of translational research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — direct 3′ UTR binding confirmed by luciferase, functional rescue performed, single lab\",\n      \"pmids\": [\"34150006\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"S. pneumoniae extracellular vesicle cargo protein StkP (a eukaryotic-like serine-threonine kinase) phosphorylates BECN1 at Ser93 and Ser96, initiating autophagy that leads to autophagosomal degradation of OCLN and alveolar epithelial barrier disruption; stkP deletion abolishes OCLN degradation and barrier dysfunction.\",\n      \"method\": \"Proteomics of pEV cargo; co-immunoprecipitation; Western blot; autophagy inhibitors (bafilomycin A1, chloroquine); CRISPR-KO of stkP; TEER/permeability assay; mouse infection model\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods including genetic deletion, pharmacological inhibition, and in vivo validation; strong mechanistic evidence\",\n      \"pmids\": [\"38497494\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"miR-20a overexpression suppresses DUSP3, which in turn reduces ubiquitination-mediated degradation of OCLN, thereby preserving intestinal barrier function in sepsis; OCLN knockdown abolishes the protective effect of miR-20a.\",\n      \"method\": \"CLP mouse model; LPS-treated NCM460 cells; Western blot; RT-qPCR; immunofluorescence; ELISA; flow cytometry; OCLN knockdown rescue experiments\",\n      \"journal\": \"In vitro cellular & developmental biology. Animal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — identifies DUSP3 as upstream regulator of OCLN ubiquitination; mechanistic pathway supported by KD/rescue but single lab\",\n      \"pmids\": [\"40392484\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"The OCLN carboxy-terminal domain forms a complex with the light intermediate chain (LIC) of dynein to link tight junction cargo to the minus-end motor; phosphorylation of S471 is required for LIC binding and S490 phosphorylation is required for trafficking. OCLN S490A mutant prevented endothelial cell proliferation and collateral angiogenesis. Full deletion of OCLN (targeting exon 5, eliminating full-length and isoform 4) caused embryonic lethality.\",\n      \"method\": \"Co-immunoprecipitation; phosphomutant (S471A, S490A) expression; endothelial cell proliferation assay; in vivo collateral angiogenesis model; exon 5-targeted OCLN knockout mice\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — reconstitution of dynein complex, mutational analysis of specific phosphosites, in vivo genetic deletion; multiple orthogonal methods in single preprint\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Occludin silencing in brain endothelial cells alters gene expression of innate immunity components including IFN-stimulated genes and the RIG-1/MAVS signaling pathway, and leads to dysfunctional mitochondrial bioenergetics, dynamics, and autophagy, worsening ischemic stroke outcomes in EcoHIV-infected occludin-deficient mice.\",\n      \"method\": \"siRNA-mediated OCLN silencing; gene expression profiling; mitochondrial bioenergetics assays; EcoHIV-infected ocln-deficient mouse ischemic stroke model\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO/KD with defined phenotypic readout in vivo and in vitro, but preprint and single lab\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"OCLN (occludin) is a tight junction integral membrane protein whose MARVEL domain is required for cell-surface localization and HCV entry; its carboxy-terminal domain acts as a dynein adaptor—linking tight junction cargo to the minus-end motor in a phosphorylation-dependent manner (S471 for LIC binding, S490 for trafficking)—and is essential for VEGF-induced vascular permeability and collateral angiogenesis; OCLN protein levels are post-translationally regulated by ubiquitination (modulated upstream by DUSP3) and by autophagosomal degradation (triggered by bacterial StkP-mediated BECN1 phosphorylation), while its mRNA is post-transcriptionally repressed by miR-122 and miR-144, collectively placing OCLN at the intersection of barrier maintenance, viral entry, innate immune signaling, and vascular remodeling.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1994,\n      \"finding\": \"Occludin's long COOH-terminal cytoplasmic domain (domain E, specifically the ~150 aa subdomain E358/504) is necessary for its localization at tight junctions and directly associates with ZO-1 (and ZO-2 complex) in vitro, suggesting that cytoskeletal anchoring through ZO-1 is required for occludin's tight junction localization.\",\n      \"method\": \"Deletion mutant transfection in epithelial cells, GST-fusion protein pulldown, in vitro binding assay with recombinant ZO-1\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro binding with mutagenesis, replicated across labs\",\n      \"pmids\": [\"7798316\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Occludin is a conserved integral membrane tight junction protein across mammals (human, mouse, dog, rat-kangaroo); mammalian homologues share ~90% amino acid identity with each other but only ~50% with chicken, establishing the conserved four-transmembrane topology across species.\",\n      \"method\": \"cDNA cloning and sequence analysis across species\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — molecular cloning with cross-species validation, single study\",\n      \"pmids\": [\"8601611\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"ZO-1 links occludin to the actin cytoskeleton: occludin interacts with a specific domain in the N-terminal (MAGUK-like) half of ZO-1, while the C-terminal proline-rich half of ZO-1 cosediments with F-actin, placing ZO-1 as a molecular bridge between the transmembrane occludin and cortical actin.\",\n      \"method\": \"Epitope-tagged ZO-1 fragment transfection in MDCK cells, in vitro binding assays, co-sedimentation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro + in vivo localization, replicated by multiple labs\",\n      \"pmids\": [\"9792688\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"ZO-3 directly interacts with both ZO-1 and the cytoplasmic domain of occludin (but not ZO-2) in vitro affinity assays, and colocalizes with ZO-1 at tight junctions, identifying ZO-3 as an additional occludin-binding scaffold at the tight junction.\",\n      \"method\": \"In vitro affinity binding assays with recombinant proteins, immunofluorescence, immunoelectron microscopy\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with structural localization, replicated\",\n      \"pmids\": [\"9531559\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Occludin directly interacts with F-actin in vitro, and ZO-2 also binds directly to occludin; in situ ZO-1, ZO-2, and ZO-3 exist primarily as independent ZO-1·ZO-2 and ZO-1·ZO-3 complexes rather than a trimeric complex, defining the molecular architecture of the tight junction plaque.\",\n      \"method\": \"Actin cosedimentation assays with purified recombinant proteins, co-immunoprecipitation from MDCK cells, immunofluorescence in cytochalasin D-treated cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro binding + in vivo co-IP, multiple orthogonal methods\",\n      \"pmids\": [\"10575001\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Oxidative stress induces tyrosine phosphorylation of occludin, causing dissociation of occludin–ZO-1 complexes from the cytoskeletal fraction and redistribution from intercellular junctions; tyrosine kinase inhibitor genistein prevents these effects and preserves transepithelial resistance, establishing that tyrosine phosphorylation of occludin regulates its association with ZO-1 and tight junction integrity.\",\n      \"method\": \"Caco-2 monolayer oxidative stress model, co-immunoprecipitation, Triton-insoluble fractionation, transepithelial resistance measurement, pharmacological inhibition\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP + fractionation + functional resistance readout + pharmacological rescue\",\n      \"pmids\": [\"12169098\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Snail transcription repressor directly binds to E-boxes in the promoters of occludin (and claudin) genes, repressing their transcription during epithelial-mesenchyme transition (EMT), thereby directly coupling EMT to loss of tight junction proteins at the transcriptional level.\",\n      \"method\": \"Snail overexpression in mouse epithelial cells, promoter reporter assays, electrophoretic mobility shift assay (EMSA), qRT-PCR and western blot for mRNA and protein\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — direct promoter binding by EMSA + functional transcriptional repression + multiple methods\",\n      \"pmids\": [\"12668723\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Occludin physically interacts with TGF-β type I receptor (identified by LUMIER technology) and regulates its localization, thereby facilitating efficient TGF-β-dependent dissolution of tight junctions during epithelial-to-mesenchymal transition.\",\n      \"method\": \"LUMIER (luminescence-based mammalian interactome mapping) high-throughput protein-protein interaction assay, functional TGF-β signaling studies\",\n      \"journal\": \"Science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — systematic interaction screen with functional follow-up, single lab\",\n      \"pmids\": [\"15761153\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"By FRAP analysis in live confluent MDCK monolayers, the majority of occludin (71%) diffuses rapidly within the tight junction membrane with a diffusion constant of ~0.011 µm²/s, in contrast to claudin-1 which is largely stable (76% immobile), demonstrating that the tight junction undergoes constant remodeling with occludin as a highly dynamic component.\",\n      \"method\": \"Fluorescence recovery after photobleaching (FRAP) in live confluent MDCK monolayers, mathematical modeling of diffusion\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — quantitative live-cell FRAP with mathematical modeling, direct localization with functional dynamics\",\n      \"pmids\": [\"18474622\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Human occludin is an essential HCV cell entry factor: overexpression of human OCLN in otherwise non-permissive murine cells renders them infectable with HCV pseudoparticles (HCVpp), and siRNA knockdown of OCLN in permissive human cells impairs both HCVpp and HCVcc infection. Together with CD81, SR-BI, and CLDN1, OCLN is required for HCV entry; species-specific determinants of OCLN were mapped to its second extracellular loop.\",\n      \"method\": \"cDNA library screening, HCVpp and HCVcc infection assays in murine cells expressing human OCLN, siRNA knockdown in permissive human cells, chimeric/domain-swap constructs\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — complementation assay in murine cells + siRNA knockdown + domain mapping, replicated by independent group\",\n      \"pmids\": [\"19182773\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"VEGF-A specifically down-regulates both claudin-5 and occludin protein and mRNA in brain microvascular endothelial cells; recombinant occludin expressed from the same promoter as CLN-5 was not protective against VEGF-induced paracellular permeability increase, whereas CLN-5 was, indicating that occludin loss contributes to but is not the primary determinant of VEGF-mediated BBB breakdown.\",\n      \"method\": \"Brain microvascular endothelial cell cultures, in vivo microinjection in mouse cerebral cortex, recombinant protein overexpression, permeability assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vitro and in vivo experiments with functional permeability readout\",\n      \"pmids\": [\"19174516\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"VEGF treatment of endothelial cells induces phosphorylation of occludin on Ser-490 and subsequent ubiquitination; phosphorylated/ubiquitinated occludin traffics from cell borders to early and late endosomes, and occludin interacts with ubiquitin-interacting motif (UIM) proteins Epsin-1, Eps15, and Hrs. Mutating Ser-490 to Ala suppresses VEGF-induced ubiquitination, blocks TJ protein trafficking, and prevents permeability increase; an occludin-ubiquitin chimera disrupts TJs and increases permeability without VEGF.\",\n      \"method\": \"Co-immunoprecipitation, immunocytochemistry, site-directed mutagenesis (S490A), occludin-ubiquitin chimera overexpression, permeability assays in endothelial cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis + chimera + Co-IP + functional permeability readout, multiple orthogonal methods\",\n      \"pmids\": [\"19478092\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Occludin (along with claudin-1) is required for HCV entry into liver cells and is downregulated during HCV infection to prevent superinfection; mutational analysis of claudin-1 showed that its tight junctional distribution is important for viral entry, supporting a model in which HCV enters from the tight junction.\",\n      \"method\": \"HCV pseudoparticle entry assays, siRNA knockdown, CLDN1 mutational analysis, HCV infection of Huh-7 cells\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — functional entry assays with knockdown and mutational analysis, independent replication of HCV entry role\",\n      \"pmids\": [\"19052094\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The OCLN gene produces multiple alternative splice variants in human liver; only the wild-type (WT-OCLN) and OCLN-ex7ext isoforms, which retain the MARVEL domain, are expressed on the cell membrane and are permissive for HCV infection in vitro. All other isoforms lacking the MARVEL domain are expressed cytoplasmically and are non-permissive, demonstrating that the MARVEL domain and membrane localization are required for occludin's HCV co-receptor function.\",\n      \"method\": \"RT-PCR cloning of splice variants from human liver, recombinant isoform expression, subcellular localization analysis, HCV infectivity assays in vitro\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — systematic isoform characterization with functional infectivity assays, multiple isoforms tested\",\n      \"pmids\": [\"20463075\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"MarvelD3 is a novel tight junction MARVEL-domain protein related to occludin and tricellulin; FRAP and protein interaction studies show these three MARVEL proteins have distinct but overlapping functions—marvelD3 can partially compensate for occludin or tricellulin loss but cannot fully restore function, defining the tight junction-associated MARVEL protein (TAMP) family with redundant and unique contributions to epithelial barrier function.\",\n      \"method\": \"siRNA knockdown, FRAP, immunofluorescence/electron microscopy, protein interaction assays, in vivo immune activation, phylogenetic analysis\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including FRAP, KD with phenotypic readout, protein interaction, in vivo\",\n      \"pmids\": [\"20164257\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Selective siRNA knockdown of occludin in Caco-2 monolayers in vitro and in mouse intestine in vivo causes a preferential increase in macromolecule flux (urea, mannitol, inulin, dextran) without affecting transepithelial resistance, demonstrating that occludin specifically regulates the large-channel tight junction pathway responsible for macromolecule permeability.\",\n      \"method\": \"siRNA knockdown in Caco-2 monolayers, in vivo mouse intestinal recycling perfusion with siRNA, transepithelial resistance measurement, flux assays with size-graded probes\",\n      \"journal\": \"American journal of physiology. Gastrointestinal and liver physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vitro and in vivo KD with specific functional readout (size-selective permeability)\",\n      \"pmids\": [\"21415414\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"miR-122 binds directly to the 3' UTR of OCLN mRNA and down-regulates occludin protein expression; miR-122 overexpression in Huh7.5 cells reduces OCLN protein by ~80%, decreases colocalization of OCLN with CLDN at tight junctions, and reduces HCV pseudoparticle entry by ~42%, establishing miR-122 as a post-transcriptional repressor of OCLN that indirectly inhibits HCV entry.\",\n      \"method\": \"Dual-luciferase reporter assay with 3'UTR construct, miR-122 mimic/inhibitor transfection, western blot, immunofluorescence co-localization, lentiviral miR-122 overexpression, HCV pseudoparticle and VSV pseudoparticle entry assays\",\n      \"journal\": \"Liver international\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct 3'UTR luciferase validation + protein knockdown + functional entry assay, multiple methods\",\n      \"pmids\": [\"25302477\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"miR-144 directly targets OCLN and ZO1 mRNA (validated by dual-luciferase assay with mutant controls); miR-144 overexpression in IBS-D rat colonic epithelial cells decreases OCLN and ZO1 expression and enhances intestinal hyperpermeability, while inhibition of miR-144 or rescue overexpression of OCLN/ZO1 reverses hyperpermeability, establishing miR-144 as a direct post-transcriptional repressor of OCLN.\",\n      \"method\": \"miRNA microarray, qRT-PCR, western blot, ELISA, dual-luciferase assay with 3'UTR mutants, miRNA mimic/inhibitor transfection, rescue overexpression experiments in colonic epithelial cells\",\n      \"journal\": \"Cellular physiology and biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — 3'UTR luciferase with mutation controls + protein expression + functional permeability + rescue experiment\",\n      \"pmids\": [\"29258088\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"S. pneumoniae releases extracellular vesicles (pEVs) containing the virulence kinase StkP; internalized StkP phosphorylates BECN1 at Ser93 and Ser96, initiating autophagy, which leads to autophagosomal degradation of OCLN and consequent alveolar epithelial barrier dysfunction. Deletion of stkP in S. pneumoniae abolishes pEV-induced OCLN degradation and protects mice from death.\",\n      \"method\": \"Proteomics of pEV cargo, co-immunoprecipitation, phosphorylation site identification, autophagy inhibitors (BafA1, CQ), BECN1 mutants, CRISPR KO of stkP, TEER measurement, in vivo mouse infection model\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic pathway from kinase to substrate to autophagy to OCLN degradation, confirmed in vivo with KO\",\n      \"pmids\": [\"38497494\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"The OCLN carboxy-terminus forms a complex with the light intermediate chain (LIC) of dynein, linking tight junction cargo to the minus-end-directed motor protein. Ser471 phosphorylation is required for LIC binding, while Ser490 phosphorylation is required for trafficking. Expression of the S490A mutant prevents endothelial cell proliferation and collateral angiogenesis. OCLN gene deletion targeting exon 5 (preventing both full-length and isoform 4 expression) results in embryonic lethality.\",\n      \"method\": \"Co-immunoprecipitation, site-directed mutagenesis (S471A, S490A), endothelial cell proliferation assays, collateral angiogenesis model, exon 5-targeted gene deletion (embryonic lethality phenotype)\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP with mutagenesis + functional cellular and in vivo phenotypes, preprint not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.06.12.659326\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Occludin silencing (ocln KD) in brain endothelial cells alters gene expression signatures of innate immunity including IFN-stimulated genes and the RIG-1/MAVS antiviral signaling pathway, and causes dysfunctional mitochondrial bioenergetics and autophagy; in EcoHIV-infected ocln-deficient mice, these alterations translate to worsened ischemic stroke outcomes, identifying occludin as a regulator of innate immune responses and mitochondrial dynamics in the BBB.\",\n      \"method\": \"Occludin siRNA knockdown in brain endothelial cells, gene expression profiling, mitochondrial bioenergetics assays, EcoHIV infection in ocln-deficient mice, ischemic stroke model\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KD with gene expression + functional mitochondrial assays + in vivo stroke model, preprint\",\n      \"pmids\": [\"bio_10.1101_2024.06.07.598027\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"miR-122-5p in LPS-induced neutrophil exosomes directly targets OCLN mRNA (validated by dual-luciferase assay), downregulates OCLN expression in brain microvascular endothelial cells, and promotes apoptosis, oxidative stress, and increased permeability; OCLN overexpression partially reverses these effects.\",\n      \"method\": \"Dual-luciferase reporter assay, western blot, exosome co-culture, flow cytometry (apoptosis), ROS assays, OCLN overexpression rescue\",\n      \"journal\": \"American journal of translational research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — 3'UTR luciferase + functional rescue, single lab\",\n      \"pmids\": [\"34150006\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"miR-20a overexpression in a sepsis model inhibits DUSP3 (a target of miR-20a), which in turn suppresses ubiquitination of OCLN, thereby preserving OCLN protein levels and intestinal barrier integrity; OCLN knockdown abolishes the protective effect of miR-20a overexpression, placing OCLN downstream of the miR-20a/DUSP3 axis in barrier regulation.\",\n      \"method\": \"CLP mouse sepsis model and LPS-treated NCM460 cells, miR-20a mimic/DUSP3 OE/KD/OCLN KD, western blot, RT-qPCR, ELISA, flow cytometry, immunofluorescence, HE staining\",\n      \"journal\": \"In vitro cellular & developmental biology. Animal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pathway epistasis with KD/OE + in vivo model, single lab\",\n      \"pmids\": [\"40392484\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Occludin (OCLN) is a four-transmembrane MARVEL-domain tight junction protein whose long COOH-terminal cytoplasmic tail directly associates with ZO-1 (and ZO-3) to anchor it to the cortical actin cytoskeleton; it acts as a highly dynamic membrane component that regulates the large-channel paracellular pathway for macromolecule flux, undergoes Ser-490 phosphorylation-driven ubiquitination to mediate VEGF-induced endosomal trafficking and vascular permeability, serves as an essential HCV co-entry factor through its second extracellular loop and MARVEL domain, is transcriptionally repressed by Snail during EMT, and—as newly described—links tight junction cargo to the dynein motor via its carboxy-terminus to regulate trafficking and collateral angiogenesis, while also modulating innate immune and mitochondrial signaling at the blood-brain barrier.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"OCLN (occludin) is a MARVEL-domain-containing integral membrane protein that serves as a core structural and regulatory component of epithelial and endothelial tight junctions, governing paracellular permeability, viral entry, and vascular remodeling. The MARVEL domain is required for cell-surface localization and is the functional unit permitting hepatitis C virus entry, while the carboxy-terminal domain acts as a dynein adaptor—binding the dynein light intermediate chain in a phosphorylation-dependent manner (S471 for LIC binding, S490 for cargo trafficking)—and is essential for endothelial cell proliferation and collateral angiogenesis [PMID:20463075]. OCLN protein levels are regulated post-translationally by ubiquitination (modulated by DUSP3) and by autophagosomal degradation triggered by S. pneumoniae StkP-mediated phosphorylation of BECN1 [PMID:38497494, PMID:40392484], and post-transcriptionally by miR-122 and miR-144, which directly target the OCLN 3′ UTR to reduce protein expression and increase barrier permeability [PMID:25302477, PMID:29258088]. Loss of OCLN in brain endothelial cells alters innate immune gene expression including the RIG-I/MAVS pathway and disrupts mitochondrial bioenergetics, linking tight junction integrity to innate immune signaling.\",\n  \"teleology\": [\n    {\n      \"year\": 2010,\n      \"claim\": \"Identifying which domain of OCLN is required for HCV entry resolved a key question about how a tight junction protein enables viral infection: the MARVEL domain is the functional unit needed for surface localization and HCV permissiveness.\",\n      \"evidence\": \"HCV infectivity assays with recombinant OCLN splice variants differing in MARVEL domain retention\",\n      \"pmids\": [\"20463075\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No structural detail of how MARVEL domain engages HCV entry factors\",\n        \"Whether MARVEL domain interactions are specific to HCV or shared with other viruses unknown\",\n        \"Mechanism by which MARVEL domain mediates surface targeting not defined\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstrating that miR-122 directly targets the OCLN 3′ UTR established a post-transcriptional regulatory axis controlling OCLN levels and, consequently, HCV entry into hepatocytes.\",\n      \"evidence\": \"Dual-luciferase reporter assay with OCLN 3′ UTR; miR-122 overexpression and HCV pseudoparticle infectivity assay\",\n      \"pmids\": [\"25302477\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Quantitative relationship between miR-122 levels and OCLN protein at endogenous stoichiometry unresolved\",\n        \"Whether miR-122 regulation of OCLN operates in non-hepatic tissues unknown\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identification of miR-144 as a second miRNA directly targeting OCLN (and ZO-1) in colonic epithelial cells broadened OCLN post-transcriptional regulation beyond the liver and linked it to intestinal barrier dysfunction.\",\n      \"evidence\": \"Dual-luciferase assay with mutant target-site controls; miR-144 mimics/inhibitors; permeability assay in IBS-D rat colonic epithelial cells; rescue by OCLN overexpression\",\n      \"pmids\": [\"29258088\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether miR-144-mediated OCLN suppression is causative in IBS-D patients not established\",\n        \"Relative contribution of OCLN vs. ZO-1 downregulation to the permeability phenotype unclear\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Revealing that S. pneumoniae StkP phosphorylates BECN1 to trigger autophagosomal degradation of OCLN defined a bacterial strategy for dismantling epithelial barriers through targeted autophagy of a specific tight junction protein.\",\n      \"evidence\": \"Proteomics of pneumococcal extracellular vesicle cargo; co-IP; autophagy inhibitors; CRISPR-KO of stkP; TEER/permeability assays; mouse infection model\",\n      \"pmids\": [\"38497494\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"How OCLN is selectively targeted for autophagosomal engulfment while other tight junction proteins are spared is unknown\",\n        \"Whether other bacterial kinases use the same BECN1-phosphorylation strategy not tested\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Discovery that DUSP3 promotes OCLN ubiquitination and degradation, with miR-20a acting upstream to suppress DUSP3, identified a phosphatase-ubiquitin axis controlling OCLN protein stability during sepsis-induced barrier injury.\",\n      \"evidence\": \"CLP mouse model; LPS-treated intestinal epithelial cells; OCLN knockdown rescue experiments; Western blot and immunofluorescence\",\n      \"pmids\": [\"40392484\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"The E3 ubiquitin ligase acting on OCLN downstream of DUSP3 is not identified\",\n        \"Single-lab finding; independent replication needed\",\n        \"Whether DUSP3 acts directly on OCLN phosphorylation or through an intermediate not determined\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Mapping the OCLN C-terminal domain as a dynein adaptor with phosphosite-specific requirements (S471 for LIC binding, S490 for trafficking) redefined OCLN from a passive barrier component to an active minus-end motor linker essential for vascular remodeling and embryonic viability.\",\n      \"evidence\": \"(preprint) Co-immunoprecipitation; S471A and S490A phosphomutant expression; collateral angiogenesis model; exon 5-targeted OCLN knockout mice\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Preprint, awaiting peer review\",\n        \"Kinase(s) responsible for S471 and S490 phosphorylation not identified\",\n        \"Structural basis of OCLN C-terminus–LIC interaction not resolved\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown how OCLN integrates its dual roles as a structural tight junction component and a dynein adaptor, and which kinases and E3 ligases directly phosphorylate and ubiquitinate OCLN to control its turnover and trafficking in different tissue contexts.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No structural model of full-length OCLN exists\",\n        \"Direct kinases for S471 and S490 unidentified\",\n        \"E3 ubiquitin ligase for OCLN degradation unknown\",\n        \"Mechanism linking OCLN loss to innate immune gene dysregulation not resolved\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1500931\", \"supporting_discovery_ids\": [0, 2, 5, 7]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"DYNC1LI1\",\n      \"BECN1\",\n      \"DUSP3\",\n      \"TJP1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"Occludin is a four-transmembrane MARVEL-domain tight junction protein that regulates paracellular permeability, particularly the large-channel pathway controlling macromolecule flux, through its dynamic residency at tight junctions and phosphorylation-dependent trafficking [PMID:21415414, PMID:18474622]. Its long COOH-terminal cytoplasmic tail directly binds ZO-1, ZO-2, ZO-3, and F-actin, anchoring it to the cortical cytoskeleton, while phosphorylation at Ser-490 drives ubiquitination and endosomal trafficking that increases vascular permeability in response to VEGF [PMID:7798316, PMID:9792688, PMID:19478092]. Occludin serves as an essential hepatitis C virus co-entry factor through its second extracellular loop and MARVEL domain, is transcriptionally repressed by Snail during epithelial-mesenchymal transition, and is post-transcriptionally downregulated by miR-122 and miR-144 [PMID:19182773, PMID:12668723, PMID:25302477, PMID:29258088]. Occludin also undergoes autophagosomal degradation triggered by pneumococcal StkP-mediated BECN1 phosphorylation, contributing to alveolar barrier disruption during infection [PMID:38497494].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"The molecular basis of occludin's tight junction localization was established by demonstrating that its COOH-terminal cytoplasmic domain directly binds ZO-1, resolving how a transmembrane protein is tethered at the junctional plaque.\",\n      \"evidence\": \"Deletion mutant transfection in epithelial cells and GST-pulldown with recombinant ZO-1\",\n      \"pmids\": [\"7798316\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Binding affinity and stoichiometry of the occludin–ZO-1 interaction were not determined\", \"Whether ZO-1 binding is required for occludin function versus merely localization was unclear\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"ZO-1 was shown to function as a molecular bridge connecting occludin to cortical actin, with additional scaffolding provided by ZO-3, establishing the tripartite architecture of the tight junction plaque.\",\n      \"evidence\": \"In vitro binding/cosedimentation assays and fragment transfection in MDCK cells for ZO-1; affinity assays and immunoelectron microscopy for ZO-3\",\n      \"pmids\": [\"9792688\", \"9531559\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the ZO-1 bridging function was not resolved\", \"Relative contributions of ZO-2 versus ZO-3 to occludin anchoring remained unclear\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Occludin was found to bind F-actin directly in addition to its indirect linkage through ZO proteins, and ZO-1·ZO-2 and ZO-1·ZO-3 were shown to exist as separate dimeric complexes rather than a single trimeric scaffold, refining the junctional plaque model.\",\n      \"evidence\": \"Actin cosedimentation with recombinant protein and co-IP from MDCK cells\",\n      \"pmids\": [\"10575001\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of direct occludin–actin binding was not tested\", \"Whether direct actin binding is regulated by phosphorylation was unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Tyrosine phosphorylation was identified as a regulatory switch for occludin–ZO-1 association and tight junction integrity, linking oxidative stress signaling to barrier disruption.\",\n      \"evidence\": \"Oxidative stress in Caco-2 monolayers with co-IP, fractionation, TER measurement, and genistein rescue\",\n      \"pmids\": [\"12169098\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific tyrosine residues phosphorylated were not identified\", \"The kinase(s) responsible were not determined\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Snail was shown to directly repress occludin transcription by binding E-box elements in its promoter, providing the first transcriptional mechanism coupling EMT to tight junction dissolution.\",\n      \"evidence\": \"Snail overexpression, promoter reporters, and EMSA in mouse epithelial cells\",\n      \"pmids\": [\"12668723\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other EMT transcription factors also target OCLN was not addressed\", \"Chromatin-level regulation was not examined\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"FRAP experiments revealed that occludin is a highly dynamic component of the tight junction (71% mobile fraction) in contrast to the largely immobile claudin-1, establishing that the tight junction undergoes constitutive remodeling driven by occludin turnover.\",\n      \"evidence\": \"Quantitative FRAP with mathematical modeling in live confluent MDCK monolayers\",\n      \"pmids\": [\"18474622\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular determinants controlling occludin's high mobility were not identified\", \"Whether dynamic exchange is required for barrier function was not tested\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Occludin was identified as an essential HCV co-entry factor, with species-specific determinants mapped to the second extracellular loop, answering why murine cells resist HCV infection and establishing OCLN alongside CD81, SR-BI, and CLDN1 as the minimal receptor complex.\",\n      \"evidence\": \"cDNA library complementation in murine cells, HCVpp/HCVcc assays, siRNA knockdown, domain-swap chimeras\",\n      \"pmids\": [\"19182773\", \"19052094\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether occludin directly contacts viral particles or acts indirectly was unresolved\", \"The step in the entry cascade requiring occludin was not pinpointed\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"VEGF-induced Ser-490 phosphorylation was shown to trigger occludin ubiquitination and endosomal trafficking via Epsin-1, Eps15, and Hrs, providing a complete signaling-to-trafficking mechanism for vascular permeability regulation.\",\n      \"evidence\": \"Site-directed mutagenesis (S490A), occludin–ubiquitin chimera, co-IP, permeability assays in endothelial cells\",\n      \"pmids\": [\"19478092\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The E3 ubiquitin ligase responsible for occludin ubiquitination was not identified\", \"Whether this pathway operates in non-endothelial epithelia was untested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Systematic isoform characterization demonstrated that MARVEL domain integrity and membrane localization are required for occludin's HCV co-receptor function, and identification of MarvelD3 defined the TAMP family with partially redundant barrier roles.\",\n      \"evidence\": \"RT-PCR isoform cloning from human liver with infectivity assays; siRNA/FRAP/EM for TAMP family analysis\",\n      \"pmids\": [\"20463075\", \"20164257\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of MARVEL domain function in HCV entry was unknown\", \"Extent of TAMP redundancy in vivo was not determined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Selective knockdown in vitro and in vivo demonstrated that occludin specifically controls the large-channel paracellular pathway for macromolecule flux without affecting ion permeability (TER), resolving its distinct functional role from claudins.\",\n      \"evidence\": \"siRNA in Caco-2 monolayers and in vivo mouse intestinal perfusion with size-graded probes\",\n      \"pmids\": [\"21415414\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural mechanism by which occludin controls large-channel permeability was not defined\", \"Whether this pathway is regulated dynamically by phosphorylation was not tested\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Post-transcriptional regulation of OCLN was established by identifying miR-122 and later miR-144 as direct repressors targeting the OCLN 3'UTR, linking microRNA networks to barrier integrity and HCV susceptibility.\",\n      \"evidence\": \"Dual-luciferase 3'UTR reporter assays, miRNA mimic/inhibitor, protein quantification, functional entry and permeability assays\",\n      \"pmids\": [\"25302477\", \"29258088\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of miR-122-mediated OCLN repression versus its direct proviral role in HCV replication was not disentangled\", \"Whether these miRNAs regulate OCLN in vivo at the BBB was unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"A pathogen-driven degradation mechanism was uncovered: pneumococcal StkP kinase phosphorylates BECN1 to initiate autophagosomal degradation of occludin, establishing autophagy as a distinct pathway for barrier disruption during bacterial infection.\",\n      \"evidence\": \"Proteomics, co-IP, phosphorylation site identification, autophagy inhibitors, BECN1 mutants, CRISPR KO of stkP, in vivo mouse infection\",\n      \"pmids\": [\"38497494\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether occludin is a direct autophagy cargo receptor substrate or is degraded indirectly was not resolved\", \"Generalizability to other bacterial infections was untested\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Occludin's COOH-terminus was found to link tight junction cargo to the dynein motor via its light intermediate chain, with Ser-471 phosphorylation required for motor engagement and Ser-490 phosphorylation required for trafficking; exon 5 deletion causes embryonic lethality, demonstrating that occludin is essential for development.\",\n      \"evidence\": \"Co-IP, site-directed mutagenesis, endothelial proliferation assays, collateral angiogenesis model, exon 5-targeted gene deletion (preprint)\",\n      \"pmids\": [\"bio_10.1101_2025.06.12.659326\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint not yet peer-reviewed\", \"Structural details of occludin–dynein LIC interface are unknown\", \"Whether dynein-mediated trafficking is relevant to all occludin-dependent barrier functions was not tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key open questions remain: the E3 ubiquitin ligase mediating VEGF-induced occludin ubiquitination has not been identified, the structural basis of the MARVEL domain's roles in barrier function and HCV entry is unresolved, and whether occludin's newly described roles in innate immunity and mitochondrial dynamics at the BBB operate through its canonical junctional function or represent junction-independent signaling remains to be dissected.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"E3 ligase identity unknown\", \"No high-resolution structure of full-length occludin\", \"Junction-independent signaling mechanisms are poorly defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098631\", \"supporting_discovery_ids\": [0, 2, 8, 15]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 2, 4, 15]},\n      {\"term_id\": \"GO:0001618\", \"supporting_discovery_ids\": [9, 12, 13]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 1, 8, 9, 13, 15]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [11]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [2, 4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1500931\", \"supporting_discovery_ids\": [0, 2, 4, 8, 15]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [5, 7, 11]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [6, 7]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [18]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [9, 12, 13]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [11]}\n    ],\n    \"complexes\": [\n      \"Tight junction plaque (ZO-1·occludin·ZO-3 scaffold)\"\n    ],\n    \"partners\": [\n      \"TJP1\",\n      \"TJP2\",\n      \"TJP3\",\n      \"CLDN1\",\n      \"MARVELD3\",\n      \"TGFBR1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}